Invesco Ltd. 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 1:42 pm Sale | 2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Invesco Ltd. IVZ | 6,449 0.000% | -1,044,906 (-99.39%) | Filing |
| 2024-11-08 09:33 am Purchase | 2024-11-08 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Invesco Ltd. IVZ | 1,051,355 6.000% | 1,051,355 (New Position) | Filing |